Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Travere Therapeutics (NASDAQ:TVTX) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 3 | 1 | 0 | 0 |
| Last 30D | 3 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 2 | 1 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts have recently evaluated Travere Therapeutics and provided 12-month price targets. The average target is $18.38, accompanied by a high estimate of $23.00 and a low estimate of $12.00. This upward trend is apparent, with the current average reflecting a 16.7% increase from the previous average price target of $15.75.
Decoding Analyst Ratings: A Detailed...
Login or create a forever free account to read this news
Sign up/Log in
